Reported 12 months ago
Cheng Loong, a metal casing manufacturer, continues its investment in the biotechnology sector by acquiring a 4.8% stake in Pacific Medical Materials through its subsidiary Yifa at an average cost of NT$89.87 per share. Following its acquisition of 20% stake in Yita Technology, Cheng Loong demonstrates a focus on high-profit and high-dividend biotechnology companies. Tai Yi, which saw profits exceeding half of its share capital in 2023, boasts a post-tax earnings per share of NT$5.8 and a dividend payout of NT$4.8 per share, equivalent to a payout ratio of 82.76%. Cheng Loong's holdings in Tai Yi exceed NT$300 million and were disclosed in compliance with regulations.
Source: YAHOO